Nuno Bernardes

1.1k total citations
26 papers, 820 citations indexed

About

Nuno Bernardes is a scholar working on Biotechnology, Molecular Biology and Ecology. According to data from OpenAlex, Nuno Bernardes has authored 26 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biotechnology, 8 papers in Molecular Biology and 6 papers in Ecology. Recurrent topics in Nuno Bernardes's work include Cancer Research and Treatments (11 papers), Bacteriophages and microbial interactions (6 papers) and Extracellular vesicles in disease (4 papers). Nuno Bernardes is often cited by papers focused on Cancer Research and Treatments (11 papers), Bacteriophages and microbial interactions (6 papers) and Extracellular vesicles in disease (4 papers). Nuno Bernardes collaborates with scholars based in Portugal, United States and Belgium. Nuno Bernardes's co-authors include Arsénio M. Fialho, Ananda M. Chakrabarty, Raquel Seruca, Dalila Mil‐Homens, Cláudia L. da Silva, Baptiste Fischer, Veerle Janssens, Péter Tompa, Johan M. Thevelein and Beatriz M. Bonini and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Nuno Bernardes

26 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuno Bernardes Portugal 14 463 205 145 129 100 26 820
Masoumeh Rajabibazl Iran 20 730 1.6× 85 0.4× 134 0.9× 93 0.7× 123 1.2× 90 1.2k
Johannes Fruehauf United States 12 559 1.2× 135 0.7× 78 0.5× 107 0.8× 82 0.8× 20 783
Rune Standal Norway 5 732 1.6× 83 0.4× 156 1.1× 90 0.7× 43 0.4× 8 1.0k
Börje Norling Sweden 18 531 1.1× 129 0.6× 82 0.6× 150 1.2× 53 0.5× 24 1.0k
Yongyi Chen China 10 544 1.2× 178 0.9× 92 0.6× 132 1.0× 31 0.3× 21 991
Hyun‐Hee Shin South Korea 22 538 1.2× 121 0.6× 94 0.6× 40 0.3× 127 1.3× 35 962
Masayo Date Japan 12 624 1.3× 174 0.8× 60 0.4× 106 0.8× 46 0.5× 18 875
Tammy‐Lynn Tremblay Canada 15 610 1.3× 41 0.2× 104 0.7× 164 1.3× 94 0.9× 28 1.0k
Gilvan Pessoa Furtado Brazil 15 484 1.0× 183 0.9× 56 0.4× 182 1.4× 26 0.3× 28 714
Fatemeh Safari Iran 14 483 1.0× 74 0.4× 48 0.3× 49 0.4× 68 0.7× 35 757

Countries citing papers authored by Nuno Bernardes

Since Specialization
Citations

This map shows the geographic impact of Nuno Bernardes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuno Bernardes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuno Bernardes more than expected).

Fields of papers citing papers by Nuno Bernardes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuno Bernardes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuno Bernardes. The network helps show where Nuno Bernardes may publish in the future.

Co-authorship network of co-authors of Nuno Bernardes

This figure shows the co-authorship network connecting the top 25 collaborators of Nuno Bernardes. A scholar is included among the top collaborators of Nuno Bernardes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuno Bernardes. Nuno Bernardes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silva, Cláudia L. da, et al.. (2024). Advancing cancer therapeutics: Integrating scalable 3D cancer models, extracellular vesicles, and omics for enhanced therapy efficacy. Advances in cancer research. 163. 137–185. 1 indexed citations
2.
Sarmento, Maria J., Luís Borges-Araújo, Sandra N. Pinto, et al.. (2021). Quantitative FRET Microscopy Reveals a Crucial Role of Cytoskeleton in Promoting PI(4,5)P2 Confinement. International Journal of Molecular Sciences. 22(21). 11727–11727. 1 indexed citations
3.
Pinto, Sandra N., et al.. (2021). The Azurin-Derived Peptide CT-p19LC Exhibits Membrane-Active Properties and Induces Cancer Cell Death. Biomedicines. 9(9). 1194–1194. 9 indexed citations
4.
Castro, Flávia, Cláudia Martins, Andreia Almeida, et al.. (2021). p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer. Journal of Controlled Release. 337. 329–342. 42 indexed citations
5.
7.
Monteiro, Gabriel A., et al.. (2020). Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines. Frontiers in Cell and Developmental Biology. 8. 471–471. 13 indexed citations
8.
Fernandes‐Platzgummer, Ana, Sunghoon Jung, William W. Milligan, et al.. (2020). Scalable Production of Human Mesenchymal Stromal Cell (MSC)-Derived Extracellular Vesicles in Microcarrier-based Bioreactors under Xeno(geneic)-free Conditions. Cytotherapy. 22(5). S23–S24. 1 indexed citations
9.
Bernardes, Nuno, Ana Fernandes‐Platzgummer, José Paulo S. Farinha, et al.. (2020). Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System. Frontiers in Cell and Developmental Biology. 8. 553444–553444. 124 indexed citations
10.
Mateus, L., et al.. (2019). Growth patterns, metabolic indicators and osteoarticular status in the Lusitano horse: A longitudinal study. PLoS ONE. 14(7). e0219900–e0219900. 7 indexed citations
12.
Fischer, Baptiste, Beatriz M. Bonini, Héctor Quezada, et al.. (2017). Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras. Nature Communications. 8(1). 922–922. 144 indexed citations
13.
Fialho, Arsénio M., Nuno Bernardes, & Ananda M. Chakrabarty. (2016). Exploring the anticancer potential of the bacterial protein azurin. AIMS Microbiology. 2(3). 292–303. 26 indexed citations
15.
Chakrabarty, Ananda M., Nuno Bernardes, & Arsénio M. Fialho. (2014). Bacterial proteins and peptides in cancer therapy. Bioengineered. 5(4). 234–242. 38 indexed citations
16.
Bernardes, Nuno, Ana Sofia Ribeiro, André Filipe Vieira, et al.. (2014). High-throughput molecular profiling of a P-cadherin overexpressing breast cancer model reveals new targets for the anti-cancer bacterial protein azurin. The International Journal of Biochemistry & Cell Biology. 50. 1–9. 19 indexed citations
17.
Bernardes, Nuno, Ananda M. Chakrabarty, & Arsénio M. Fialho. (2013). Engineering of bacterial strains and their products for cancer therapy. Applied Microbiology and Biotechnology. 97(12). 5189–5199. 61 indexed citations
18.
Fialho, Arsénio M., Nuno Bernardes, & Ananda M. Chakrabarty. (2011). Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents. Recent Patents on Anti-Cancer Drug Discovery. 7(1). 31–55. 14 indexed citations
19.
Bernardes, Nuno, Ana Sofia Ribeiro, Raquel Seruca, Joana Paredes, & Arsénio M. Fialho. (2011). Bacterial protein azurin as a new candidate drug to treat untreatable breast cancers. 1–4. 4 indexed citations
20.
Bernardes, Nuno, Raquel Seruca, Ananda M. Chakrabarty, & Arsénio M. Fialho. (2010). Microbial-based therapy of cancer: Current progress and future prospects. PubMed. 1(3). 178–190. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026